The largest database of trusted experimental protocols

5 protocols using ripa lysis buffer 1

1

Western Blot Analysis of VEGF, Notch1, and Hes1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six rats per group were used for western blot detection at the corresponding sampling time. Before protein cleavage, PMSF (Sangon Biotech) was added to RIPA Lysis Buffer I (Sangon Biotech), lysed on ice for 1 h, and the supernatant was collected. After that, the protein concentration was measured by the BCA method. Absorb 50 g of protein per sample's concentration, mix with loading buffer in a 4:1 ratio, and dilute to 20 L. Fill it up with ddH2O. The concentrated gel and separation gel electrophoresis voltages are 80 V and 100 V. Electrophoresis is complete when bromophenol blue reaches the bottom of the gel. The PVDF membrane was blocked in 5% skim milk for 2 h after the protein sample was transferred. After blocking, the membrane was gently washed with TBST, rabbit anti‐VEGFA (1:100, Santa Cruz Biotechnology), mouse anti‐Notch1 (1:100, Santa Cruz Biotechnology), and rabbit anti‐Hes1 (1:100, Santa Cruz Biotechnology). Antibodies were incubated overnight at 4°C. After 16 h, the membrane was taken out and washed on the TBST shaker for 3−5 min. After washing, add anti‐HRP goat anti‐mouse IgG‐Fc II (Cell Signaling Technology) and shake for 1 h. Darkroom imaging with ECL color developing solution. ImageJ software was used to measure the gray value of VEGFA, Notch1, Hes1, and ‐actin proteins. Finally, the final relative expression was compared according to the ratio.
+ Open protocol
+ Expand
2

Western Blot Analysis of Apoptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted from the cells with RIPA Lysis Buffer I (Sangon Biotech), and the concentration was determined according to standard protocols of the BCA Protein Assay Kit (Sangon Biotech). The total protein (30 μg/well) in the supernatant was separated by 10% SDS-PAGE and then transferred to PVDF membranes. After blocking with 5% skimmed milk at room temperature for 2 h, the membrane was incubated with primary antibodies against galectin-3 (dilution 1 : 1000; cat. no. ab209344; Abcam, UK), LC3B (dilution 1 : 1000; cat. no. ab192890; Abcam), caspase 3 (dilution 1 : 1000; cat. no. ab32351; Abcam), caspase 9 (dilution 1 : 1000; cat. no. ab32539; Abcam), cytochrome 9 (dilution 1 : 2000; cat. no. ab134909; Abcam), Bax (dilution 1 : 1000; cat. no. ab32503; Abcam), Bcl-2 (dilution 1 : 1500; cat. no. ab32124; Abcam), and GAPDH (dilution 1 : 5000; cat. no. ab8245; Abcam) at 4°C overnight and then incubated with secondary antibodies (dilution 1 : 10,000; cat. no. ab6940; Abcam) for 2 h at room temperature. The immunoreactive bands were visualized using an enhanced chemiluminescence reagent (Sangon Biotech). The blots were semiquantified by ImageJ software (National Institutes of Health).
+ Open protocol
+ Expand
3

Exosomal Protein Profiling via Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exosomes were lysed with RIPA Lysis Buffer I (Sangon Biotech, Cat: C500005) to obtain the total protein. The protein concentration of each sample was determined using a NanoDrop™ spectrophotometer (Thermo Fisher Scientific, Cat: A30221). Protein (100 µg) from each sample was subjected to SDS-PAGE (4% stacking and 10% separating gels) and then transferred overnight onto polyvinylidene fluoride membranes (Millipore, Billerica, MA, United States). The primary antibodies used here included anti-human TJP1 antibody (Abcam, Cat: AB216880), anti-CDH2 antibody (Abcam, Cat: AB76057), anti-VIM antibody (Abcam, Cat: AB 137321), anti-EPS15 antibody (Abcam, Cat: AB224811), anti-GAPDH antibody (Abcam, Cat: AB8245), and anti-Flag antibody (Abcam, Cat: AB1162).
+ Open protocol
+ Expand
4

Exosomal Protein Characterization by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exosomes were lysed with RIPA Lysis Buffer I (Sangon Biotech, Cat: C500005) to obtain the total protein. Then, the extracted proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a nitrocellulose membrane. The primary antibodies used here included: anti-CD9 (Abclonal, Cat: A1703), anti-CD63 (Abclonal, Cat: A5271), anti-TSG101 (Abclonal, Cat: A1692), and anti-HSPA5 (Abclonal, Cat:A11366).
+ Open protocol
+ Expand
5

Protein Expression Analysis in HaCaT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as previously described to determine the protein expression levels of Akt, p-Akt, Erk, p-Erk, and proliferating cell nuclear antigen (PCNA) in tissues from HaCaT cells treated for 0, 5, 15, 30, 60, 120, or 240 min or 3 days [18] . In brief, proteins were homogenized in 10 volumes of RIPA lysis buffer I (C500005, Sangon Biotech, Shanghai, China); next, equal amounts of proteins (10 -20 μg) were fractionated on a 15% SDS-PAGE gel and were then transferred to nitrocellulose membranes. The membranes were blocked with blocking buffer (5% nonfat dairy milk dissolved in TBS containing 0.05% Tween-20 (TBS-T)) overnight at 4°C. They were then incubated with the following primary antibodies: anti-Akt (1:1000; #9272s, Cell Signaling Technology, Shanghai, China), anti-p-Akt (1:1000; #4051s, Cell Signaling Technology, Shanghai, China), anti-Erk (1:1000; #4695s, Cell Signaling Technology, Shanghai, China), antip-Erk (1:1000; #4370s, Cell Signaling Technology, Shanghai, China), anti-PCNA (1:1000; #AB20014, BBI Life Science, New York, USA) and anti-TUBA4A (1:500) and a secondary antibody (#AB10058, BBI Life Science, New York, USA). Following three washes in TBS-T, the proteins were detected using an enhanced chemiluminescence (ECL; Abcam) kit according to the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!